http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 30 Jul 2026 17:29:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++CERUS+CORP+++++++++++++++++++++++++++/26844981.html si-local-file:///var/storage/secattach/20260730/26844981.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++CERUS+CORP+++++++++++++++++++++++++++/26844981.html Thu, 30 Jul 2026 17:29:00 -0400 CERS O.00178613 http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++CERUS+CORP+++++++++++++++++++++++++++/26844981.html si-local-file:///var/storage/secattach/20260730/26844981.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++CERUS+CORP+++++++++++++++++++++++++++/26844981.html Thu, 30 Jul 2026 17:29:00 -0400 CERS O.00178613 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CERUS+CORP++++++++++++++++For%3A+Jun+30/26844475.html si-local-file:///var/storage/secattach/20260730/26844475.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CERUS+CORP++++++++++++++++For%3A+Jun+30/26844475.html Thu, 30 Jul 2026 16:44:00 -0400 CERS O.00178613 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CERUS+CORP++++++++++++++++For%3A+Jun+30/26844475.html si-local-file:///var/storage/secattach/20260730/26844475.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CERUS+CORP++++++++++++++++For%3A+Jun+30/26844475.html Thu, 30 Jul 2026 16:44:00 -0400 CERS O.00178613 http://www.streetinsider.com/Earnings/Cerus+%28CERS%29+Tops+Q2+EPS+by+2c+%3B+Offers+Guidance/26843521.html <p>Cerus (NASDAQ: CERS) reported Q2 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $63.3 million versus the consensus estimate of $62.9 million.</p><p><strong>GUIDANCE:</strong></p><p>Cerus sees FY2026 revenue of $229-231 million, versus the consensus of $238.1 million.</p><p>For earnings history and earnings-related data on Cerus (CERS) <a href="http://www.streetinsider.com/ec_earnings.php?q=CERS">click here</a>.</p> http://www.streetinsider.com/Earnings/Cerus+%28CERS%29+Tops+Q2+EPS+by+2c+%3B+Offers+Guidance/26843521.html Thu, 30 Jul 2026 16:05:57 -0400 CERS http://www.streetinsider.com/Guidance/Cerus+%28CERS%29+Tops+Q2+EPS+by+2c+%3B+Offers+Guidance/26843521.html <p>Cerus (NASDAQ: CERS) reported Q2 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $63.3 million versus the consensus estimate of $62.9 million.</p><p><strong>GUIDANCE:</strong></p><p>Cerus sees FY2026 revenue of $229-231 million, versus the consensus of $238.1 million.</p><p>For earnings history and earnings-related data on Cerus (CERS) <a href="http://www.streetinsider.com/ec_earnings.php?q=CERS">click here</a>.</p> http://www.streetinsider.com/Guidance/Cerus+%28CERS%29+Tops+Q2+EPS+by+2c+%3B+Offers+Guidance/26843521.html Thu, 30 Jul 2026 16:05:57 -0400 CERS http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CERUS+CORP++++++++++++++++For%3A+Jul+30/26843388.html si-local-file:///var/storage/secattach/20260730/26843388.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CERUS+CORP++++++++++++++++For%3A+Jul+30/26843388.html Thu, 30 Jul 2026 16:04:00 -0400 CERS O.00178613 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CERUS+CORP++++++++++++++++For%3A+Jul+30/26843388.html si-local-file:///var/storage/secattach/20260730/26843388.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CERUS+CORP++++++++++++++++For%3A+Jul+30/26843388.html Thu, 30 Jul 2026 16:04:00 -0400 CERS O.00178613 http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Press+Releases/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html <p class="bwalignc"> <i>Second Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y</i> </p><p class="bwalignc"> <i>Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; <br></br></i><i>Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y</i> </p> <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2026, and provided a business update. </p><p> “This quarter we made significant progress in expanding patient access to safer blood components around the globe,” said Vivek Jayaraman, Cerus’ president and chief executive officer. “I’m http://www.streetinsider.com/Business+Wire/Cerus+Corporation+Announces+Second+Quarter+2026+Financial+Results/26843292.html Thu, 30 Jul 2026 16:01:00 -0400 A.06822034 A.60012002 CERS O.00178613 O.20026344 O.69857460 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CERUS+CORP++++++++++++++++For%3A+Jul+16++Filed+by%3A+Jayaraman+Vivek+K/26790371.html si-local-file:///var/storage/secattach/20260720/26790371.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CERUS+CORP++++++++++++++++For%3A+Jul+16++Filed+by%3A+Jayaraman+Vivek+K/26790371.html Mon, 20 Jul 2026 17:04:00 -0400 CERS O.00178613 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CERUS+CORP++++++++++++++++For%3A+Jul+16++Filed+by%3A+Jayaraman+Vivek+K/26790371.html si-local-file:///var/storage/secattach/20260720/26790371.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CERUS+CORP++++++++++++++++For%3A+Jul+16++Filed+by%3A+Jayaraman+Vivek+K/26790371.html Mon, 20 Jul 2026 17:04:00 -0400 CERS O.00178613 http://www.streetinsider.com/SEC+Filings/Form++144++++++++CERUS+CORP+++++++++++++++++++++++++++++Filed+by%3A+Jayaraman+Vivek+K/26779875.html si-local-file:///var/storage/secattach/20260716/26779875.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++CERUS+CORP+++++++++++++++++++++++++++++Filed+by%3A+Jayaraman+Vivek+K/26779875.html Thu, 16 Jul 2026 16:15:00 -0400 CERS O.00178613 http://www.streetinsider.com/SEC+Filings/Form++144++++++++CERUS+CORP+++++++++++++++++++++++++++++Filed+by%3A+Jayaraman+Vivek+K/26779875.html si-local-file:///var/storage/secattach/20260716/26779875.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++CERUS+CORP+++++++++++++++++++++++++++++Filed+by%3A+Jayaraman+Vivek+K/26779875.html Thu, 16 Jul 2026 16:15:00 -0400 CERS O.00178613 http://www.streetinsider.com/Press+Releases/Cerus+Corporation+to+Release+Second+Quarter+2026+Financial+Results+on+July+30%2C+2026/26779538.html <p> CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2026 financial results will be released on Thursday, July 30, 2026, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Company’s financial results and provide a general business overview and outlook. </p><p> To listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at <a target="_blank" href="http://ir.cerus.com">http://ir.cerus.com</a>. Participants may register for the call <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fzg36tzdx&amp;esheet=54571512&amp;newsitemid=20260716806393&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=b8c46f054152f8426b5c111bd8662c6e" shape="rect">here</a>. While http://www.streetinsider.com/Press+Releases/Cerus+Corporation+to+Release+Second+Quarter+2026+Financial+Results+on+July+30%2C+2026/26779538.html Thu, 16 Jul 2026 16:01:00 -0400 CERS O.00178613